Tower Research Capital LLC (Trc) Citius Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,044 shares of CTXR stock, worth $10,473. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,044

Previous 43,521 90.71%

Holding current value

$10,473

Previous $25,000 92.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.48 - $1.02 $18,948 - $40,266	-39,477 Reduced 90.71%	4,044 $2,000
Q2 2024 Aug 13, 2024	BUY	$0.58 - $1.03 $20,490 - $36,387	35,328 Added 431.2%	43,521 $25,000
Q1 2024 May 15, 2024	SELL	$0.6 - $0.9 $2,989 - $4,484	-4,983 Reduced 37.82%	8,193 $7,000
Q4 2023 Feb 13, 2024	SELL	$0.65 - $0.86 $2,091 - $2,767	-3,218 Reduced 19.63%	13,176 $10,000
Q3 2023 Nov 14, 2023	BUY	$0.65 - $1.25 $4,823 - $9,275	7,420 Added 82.68%	16,394 $11,000
Q2 2023 Aug 14, 2023	BUY	$1.08 - $1.65 $9,691 - $14,807	8,974 New	8,974 $10,000
Q4 2022 Feb 10, 2023	SELL	$0.79 - $1.28 $2,703 - $4,380	-3,422 Reduced 86.0%	557 $0
Q3 2022 Nov 10, 2022	BUY	$0.14 - $1.33 $557 - $5,292	3,979 New	3,979 $5,000
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.87 $5,876 - $12,487	-6,678 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$1.38 - $1.89 $6,479 - $8,873	-4,695 Reduced 41.28%	6,678 $12,000
Q4 2021 Feb 14, 2022	BUY	$1.51 - $2.2 $3,016 - $4,395	1,998 Added 21.31%	11,373 $17,000
Q3 2021 Nov 15, 2021	SELL	$1.74 - $2.6 $1,254 - $1,874	-721 Reduced 7.14%	9,375 $19,000
Q2 2021 Aug 16, 2021	SELL	$1.51 - $4.23 $60,792 - $170,299	-40,260 Reduced 79.95%	10,096 $35,000
Q1 2021 May 17, 2021	BUY	$1.04 - $2.34 $52,370 - $117,833	50,356 New	50,356 $90,000
Q4 2020 Feb 16, 2021	SELL	$0.9 - $1.2 $7,588 - $10,118	-8,432 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$0.83 - $1.51 $16,009 - $29,124	-19,288 Reduced 69.58%	8,432 $9,000
Q2 2020 Aug 13, 2020	BUY	$0.65 - $1.45 $18,018 - $40,194	27,720 New	27,720 $31,000
Q1 2018 May 15, 2018	SELL	$2.84 - $4.46 $0 - $0	0 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$2.65 - $5.1 $0 - $0	0	0 $0

Others Institutions Holding CTXR

# of Institutions

Shares Held

23.7M

Call Options Held

83.1K

Put Options Held

32.1K

View Full List

About Citius Pharmaceuticals, Inc.

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $378M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

More about CTXR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Citius Pharmaceuticals, Inc. Transaction History